Why LifeMD, Inc.’s (LFMD) Stock Is Down 7.11%
As of Friday, July 17, LifeMD, Inc.’s LFMD share price has dipped by 7.11%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Commentary & Analysis
Why LifeMD, Inc.’s (LFMD) Stock Is Down 6.20%
As of Tuesday, July 14, LifeMD, Inc.’s LFMD share price has dipped by 6.20%, which has investors questioning if this is right time to buy.Jenna Brashear
Why LifeMD, Inc.’s (LFMD) Stock Is Up 7.07%
As of Thursday, July 02, LifeMD, Inc.’s LFMD share price has surged by 7.07%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why LifeMD, Inc.’s (LFMD) Stock Is Up 5.21%
As of Wednesday, July 01, LifeMD, Inc.’s LFMD share price has surged by 5.21%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why LifeMD, Inc.’s (LFMD) Stock Is Up 5.92%
As of Tuesday, June 23, LifeMD, Inc.’s LFMD share price has surged by 5.92%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | LFMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $169.3 | $179.6 | 26% |
|
| Shares Out (Mil) | 47.3 | 47.9 | 47% |
|
| Institutional Ownership | 75.3% | 78.6% | 46% |
|
| Float (Mil) | 40.1 | 40.1 | 42% |
|
| Beta | 2.02 | 1.22 | 92% |
|
| Avg Daily Volume (000s) | 830 | 205 | 67% |
|
| Price Change (52-week) |
(65.3%) | 41.0% | 10% |
|
| Growth | LFMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 39.1% | 13.7% | 93% |
|
| Net Income (5yr) | 17.6% | (1.0%) | 69% |
|
| EPS (5yr) | 15.5% | 15.5% | 58 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (41.2%) | (15.5%) | 11% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.045) | $0.135 | $0.515 | |
| Month Ago EPS | ($0.045) | $0.135 | $0.515 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | $0.015 | $0.140 | $0.445 | |
| Year/Year Chg | (77.9%) | (141.7%) | (337.7%) | |
| Financials | LFMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $193 | $192 | 32% |
|
| Net Income (TTM) (Mil) | $6 | ($9) | 43% |
|
| EPS (TTM) | $0.055 | ($0.500) | 42% |
|
| Operating Cash Flow (TTM) (Mil) | $8 | $8 | 37% |
|
| Net Cash Flow (TTM) (Mil) | $0 | ($3) | 44% |
|
| Long-Term Debt (Q1) (Mil) | $6 | $14 | 25% |
|
| Enterprise Value (Q1) (Mil) | $179 | $215 | 25% |
|
| Valuation | LFMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 10.94 | 1.22 | 91% |
|
| P/E | na | 36.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.0 | na |
|
| Ratios | LFMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 86.8% | 61.6% | 92% |
|
| Net Margin | 2.9% | (29.3%) | 41% |
|
| ROA | 7.9% | (21.9%) | 83% |
|
| ROE | 89.2% | (1.4%) | 96% |
|
| Liabilities to Assets | 78.6% | 33.3% | 74% |
|
| F-Score | 5 | 4 | na |
|
LifeMD, Inc. did not pass any screens on 7/31/2026.
